1. Home
  2. TFX vs BRKR Comparison

TFX vs BRKR Comparison

Compare TFX & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TFX
  • BRKR
  • Stock Information
  • Founded
  • TFX 1943
  • BRKR 1960
  • Country
  • TFX United States
  • BRKR United States
  • Employees
  • TFX N/A
  • BRKR N/A
  • Industry
  • TFX Medical/Dental Instruments
  • BRKR Biotechnology: Laboratory Analytical Instruments
  • Sector
  • TFX Health Care
  • BRKR Industrials
  • Exchange
  • TFX Nasdaq
  • BRKR Nasdaq
  • Market Cap
  • TFX 5.8B
  • BRKR 5.3B
  • IPO Year
  • TFX N/A
  • BRKR 2000
  • Fundamental
  • Price
  • TFX $125.80
  • BRKR $33.27
  • Analyst Decision
  • TFX Hold
  • BRKR Buy
  • Analyst Count
  • TFX 9
  • BRKR 11
  • Target Price
  • TFX $141.57
  • BRKR $50.00
  • AVG Volume (30 Days)
  • TFX 599.7K
  • BRKR 4.7M
  • Earning Date
  • TFX 10-30-2025
  • BRKR 11-04-2025
  • Dividend Yield
  • TFX 1.08%
  • BRKR 0.60%
  • EPS Growth
  • TFX N/A
  • BRKR N/A
  • EPS
  • TFX 4.18
  • BRKR 0.52
  • Revenue
  • TFX $3,041,342,000.00
  • BRKR $3,442,800,000.00
  • Revenue This Year
  • TFX $10.39
  • BRKR $4.44
  • Revenue Next Year
  • TFX $10.67
  • BRKR $1.71
  • P/E Ratio
  • TFX $30.20
  • BRKR $63.98
  • Revenue Growth
  • TFX 1.11
  • BRKR 10.36
  • 52 Week Low
  • TFX $108.90
  • BRKR $28.53
  • 52 Week High
  • TFX $249.91
  • BRKR $72.94
  • Technical
  • Relative Strength Index (RSI)
  • TFX 49.72
  • BRKR 50.90
  • Support Level
  • TFX $125.05
  • BRKR $30.31
  • Resistance Level
  • TFX $129.29
  • BRKR $34.44
  • Average True Range (ATR)
  • TFX 2.97
  • BRKR 1.48
  • MACD
  • TFX -0.80
  • BRKR 0.38
  • Stochastic Oscillator
  • TFX 23.52
  • BRKR 80.20

About TFX Teleflex Incorporated

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

About BRKR Bruker Corporation

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.

Share on Social Networks: